|
Volumn 51, Issue 5, 2007, Pages 644-645
|
The propofol infusion syndrome treated with haemofiltration. Is there a time for genetic screening? [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATINE KINASE;
HYPERTENSIVE FACTOR;
MYOGLOBIN;
POTASSIUM;
PROPOFOL;
REMIFENTANIL;
TRIACYLGLYCEROL;
ADULT;
BLOOD PRESSURE REGULATION;
BRAIN PERFUSION;
CASE REPORT;
CONTINUOUS HEMOFILTRATION;
CONTINUOUS INFUSION;
CREATINE KINASE BLOOD LEVEL;
DRUG INDUCED DISEASE;
DRUG WITHDRAWAL;
FEMALE;
GENETIC SCREENING;
HEAD INJURY;
HEART FAILURE;
HUMAN;
HYPERKALEMIA;
HYPERLIPIDEMIA;
HYPOKINESIA;
INTRACRANIAL HYPERTENSION;
INTRACRANIAL PRESSURE;
KIDNEY FAILURE;
LETTER;
MEAN ARTERIAL PRESSURE;
METABOLIC ACIDOSIS;
MUSCLE ATROPHY;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
PROPOFOL INFUSION SYNDROME;
RENAL REPLACEMENT THERAPY;
SEDATION;
TRANSESOPHAGEAL ECHOCARDIOGRAPHY;
TREATMENT OUTCOME;
TRIACYLGLYCEROL BLOOD LEVEL;
ADULT;
ANESTHESIA, INTRAVENOUS;
CRANIOCEREBRAL TRAUMA;
FEMALE;
GENETIC SCREENING;
HEMOFILTRATION;
HUMANS;
HYPNOTICS AND SEDATIVES;
PROPOFOL;
SYNDROME;
|
EID: 34147102834
PISSN: 00015172
EISSN: 13996576
Source Type: Journal
DOI: 10.1111/j.1399-6576.2007.01266.x Document Type: Letter |
Times cited : (14)
|
References (5)
|